OptimizeRx Corp. (NASDAQ: OPRX) is a Healthcare company (Medical - Healthcare Information Services) with a market capitalization of $131M. The Maz Rating grades it against the other companies in its sector.
OptimizeRx Corp.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $6.94, OptimizeRx Corp. trades at 26.2x trailing earnings, 1.4x sales and 1.0x book value, with an EV/EBITDA of 7.5. Over the last twelve months it generated about $95M of revenue and $5M of net income. It runs a gross margin of 74.2%, an operating margin of 12.6% and a net margin of 5.3%. It shows return on equity of 3.8%, return on invested capital of 4.7% and a free cash flow yield of 15.2%. On the balance sheet: a debt-to-equity ratio of 0.10 and a current ratio of 5.06. Over the past 52 weeks the share price ranged from $4.54 to $15.59, with a beta of 1.15.
OptimizeRx Corp. does not currently pay a dividend.
15 Wall Street analyst ratings cover the stock: 11 Buy and 4 Hold, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.